Monoclonal antibody to SARS-CoV-2 Spike RBD
R1-164-100
Datasheet as| Name | Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 36A7 |
| Immunogen | RBD protein SARS-CoV-2 |
| Immunogen Description | Recombinant SARS-CoV-2 RBD2 protein produced by CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line |
| Clonality | Recombinant human monoclonal |
| Clone | 36A7 |
| Class | Human IgG1-lambda |
| Reactivity | SARS-CoV-2 Spike RBD Neutralizing properties: blocks S1 and ACE2 binding in Octet system; IC50 1250 ng/ml measured in live virus neutralization assay |
| Dissociation constant (KD) | 6.27 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein)
5.10 x 10-8 M (measured against SARS-CoV-2 Spike S1 protein) |
| Application | ELISA, WB |
| Protocol | Indirect ELISA 0.04 – 0.08 ng/ml |
| Purification | Protein A affinity chromatography following desalting |
| Buffer | PBS pH 7.4 |
| Unit Size | 100 µg |
| Shipping | Shipped on dry ice |
| Storage | Store at -20 °C to -70 °C long term. Avoid multiple freeze-thaw cycles. |
| Limitations | This product is for research use only. |
Buy now
€300 / 100µg
€500 / 500µg
€745 / 1000µg
custom quantity - ask quotation